China Launches Trial Program Of Free Blood To Poor Patients
This article was originally published in PharmAsia News
China has begun a program in a district of Shanghai to provide free blood to poor patients, particularly those with leukemia, cancer and severe anemia. In addition to helping the poor, the trial program also is designed to encourage more blood donations and provide added benefits for donors and their family members. The trial in Shanghai's Xuhui District is aimed at about 10,000 poor families with seriously ill members who need either regular or large amounts of blood. (Click here for more
You may also be interested in...
The US FDA’s decision to ask on device adverse event reports whether the device involved had been serviced by a third party could help the agency as well as device makers, says Ricki Chase, compliance practice director at Lachman Consultant Services.
The FDA has almost 30 decision dates coming up before New Year’s Eve, including nearly a dozen novel agents.
Complaint lists host of problems with implementation of the rule that allows states to sponsor programs to import certain prescription drugs from Canada; at least six states have enacted legislation to sponsor these programs.